These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33616637)
1. New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes. Kolte D; Libby P; Jang IK JAMA; 2021 Mar; 325(11):1043-1044. PubMed ID: 33616637 [No Abstract] [Full Text] [Related]
2. Diagnosis and management of STEMI arising from plaque erosion. Holmes DR; Lerman A; Moreno PR; King SB; Sharma SK JACC Cardiovasc Imaging; 2013 Mar; 6(3):290-6. PubMed ID: 23473111 [No Abstract] [Full Text] [Related]
3. EROSION Study (Effective Anti-Thrombotic Therapy Without Stenting: Intravascular Optical Coherence Tomography-Based Management in Plaque Erosion): A 1-Year Follow-Up Report. Xing L; Yamamoto E; Sugiyama T; Jia H; Ma L; Hu S; Wang C; Zhu Y; Li L; Xu M; Liu H; Bryniarski K; Hou J; Zhang S; Lee H; Yu B; Jang IK Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246916 [TBL] [Abstract][Full Text] [Related]
9. Management and Outcome of Patients With Acute Coronary Syndrome Caused by Plaque Rupture Versus Plaque Erosion: An Intravascular Optical Coherence Tomography Study. Hu S; Zhu Y; Zhang Y; Dai J; Li L; Dauerman H; Soeda T; Wang Z; Lee H; Wang C; Zhe C; Wang Y; Zheng G; Zhang S; Jia H; Yu B; Jang IK J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28235809 [TBL] [Abstract][Full Text] [Related]
10. Bivalirudin: treatment effect versus side effect. Hudzik B; Gorol J; Szkodzinski J; Lekston A; Polonski L Cardiovasc Ther; 2014 Jun; 32(3):127. PubMed ID: 24612465 [No Abstract] [Full Text] [Related]
11. Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome. Weitz JI Thromb Haemost; 2014 Nov; 112(5):924-31. PubMed ID: 25030773 [TBL] [Abstract][Full Text] [Related]
12. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. Pride YB; Tung P; Mohanavelu S; Zorkun C; Wiviott SD; Antman EM; Giugliano R; Braunwald E; Gibson CM; JACC Cardiovasc Interv; 2010 Aug; 3(8):806-11. PubMed ID: 20723851 [TBL] [Abstract][Full Text] [Related]
13. Current antithrombotic management of ST elevation acute coronary syndromes in the cath lab--a paradigm shift. Cortese B Curr Vasc Pharmacol; 2012 Jul; 10(4):442. PubMed ID: 22339251 [No Abstract] [Full Text] [Related]
14. Physiological Predictors of Acute Coronary Syndromes: Emerging Insights From the Plaque to the Vulnerable Patient. Ford TJ; Berry C; De Bruyne B; Yong ASC; Barlis P; Fearon WF; Ng MKC JACC Cardiovasc Interv; 2017 Dec; 10(24):2539-2547. PubMed ID: 29268883 [TBL] [Abstract][Full Text] [Related]
15. Reply to letter: Age and sex effects on the single- and multiple-dose safety and pharmacokinetics of the new renin inhibitor ACT-178882. Dingemanse J Cardiovasc Ther; 2014 Jun; 32(3):128-9. PubMed ID: 24571428 [No Abstract] [Full Text] [Related]
16. Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention. Alfredsson J; Roe MT Drug Saf; 2015 May; 38(5):481-91. PubMed ID: 25829216 [TBL] [Abstract][Full Text] [Related]
17. Thrombus aspiration: Suck it up and keep looking for a niche. Blankenship JC Catheter Cardiovasc Interv; 2016 Nov; 88(5):725-726. PubMed ID: 27865076 [No Abstract] [Full Text] [Related]